| 英文名称 |
中文名称 |
CAS号 |
操作 |
| (-)MK-801 maleate |
(-)-MK801MALEATE |
121917-57-5 |
详细
|
| 5S rRNA modificator |
FAI |
1415238-77-5 |
详细
|
| AC55541 |
AC-55541 |
916170-19-9 |
详细
|
| ACY-241 |
|
|
详细
|
| 6H05 |
6H05 (6H零5) |
1469338-01-9 |
详细
|
| AM 580 |
4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)甲酰氨基]苯甲酸 |
102121-60-8 |
详细
|
| ARRAY-543 |
|
|
详细
|
| AVL-301 |
CO1686 |
1374640-70-6 |
详细
|
| BMS-833923 |
BMS-833923 |
1059734-66-5 |
详细
|
| BML-190 |
2-[1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-基]-1-(4-吗啉基)乙酮 |
2854-32-2 |
详细
|
| AT7519 HCl |
N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐 |
902135-91-5 |
详细
|
| ATB 346 |
ATB 346 |
1226895-20-0 |
详细
|
| APY29 |
APY29 |
1216665-49-4 |
详细
|
| APY0201 |
化合物APY0201 |
1232221-74-7 |
详细
|
| brd-4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
详细
|
| Clemizole.HCl |
1-[(4-氯苯基)甲基]-2-(吡咯烷-1-基甲基)苯并咪唑盐酸盐 |
1163-36-6 |
详细
|
| CHIR99021 |
CHIR-99021 |
252917-06-9 |
详细
|
| CX-6258 |
(Z)-5-CHLORO-3-((5-(3-(4-METHYL-1,4-DIAZEPANE-1-CARBONYL)PHENYL)FURAN-2-YL)METHYLENE)INDOLIN-2-ONE.HCL |
1202916-90-2 |
详细
|
| CM 346(Obenoxazine) |
4-(2-(5-ETHOXY-1H-BENZO[D]IMIDAZOL-2-YLTHIO)ETHYL)MORPHOLINE |
173352-21-1 |
详细
|
| CP-640186 |
(R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL |
591778-68-6 |
详细
|
| Clemizole |
吡咯咪唑 |
442-52-4 |
详细
|
| bx-795 |
N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺 |
702675-74-9 |
详细
|
| CNX1315 |
|
|
详细
|
| B-Raf-IN-1 |
苯甲酰胺 |
950736-05-7 |
详细
|
| CW069 |
CW069 |
1594094-64-0 |
详细
|
| CI-994 |
4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 |
112522-64-2 |
详细
|
| CX-5461 |
CX-5461 |
1138549-36-6 |
详细
|
| CGI 1746 |
N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 |
910232-84-7 |
详细
|
| Casin |
CASIN |
425399-05-9 |
详细
|
| CB-839 |
CB-839 |
1439399-58-2 |
详细
|
| GNE-7915 |
GNE7915 |
1351761-44-8 |
详细
|
| EPZ015666 |
EPZ015666 |
1616391-65-1 |
详细
|
| Cyclo(RGDfK) |
CYCLO (RGDFK) |
161552-03-0 |
详细
|
| GSK-923295 |
3-氯-N-{(1S)-2-[(N,N-二甲基甘氨酰)氨基]-1-[(4-{8-[(1S)-1-羟基乙基]咪唑并[1,2-A]吡啶-2-基}苯基)甲基]乙基}-4-[(1-甲基乙基)氧基]苯甲酰胺 |
1088965-37-0 |
详细
|
| IWP-2 |
IWP-2 |
686770-61-6 |
详细
|
| ELR-510444 |
ELR-510444 |
1233948-35-0 |
详细
|
| FRAX 597 |
FRAX597 |
1286739-19-2 |
详细
|
| HPGDS-inhibitor-1 |
6-(3-氟苯基)-N-[1-(2,2,2-三氟乙基)-4-哌啶基]-3-吡啶羧酰胺 |
1033836-12-2 |
详细
|
| HTH-01-015 |
无中文名称 |
1613724-42-7 |
详细
|
| GBR 12935 2HCl |
GBR-12935 dihydrochloride |
67469-81-2 |
详细
|
| Fexaramine |
FEXARAMINE |
574013-66-4 |
详细
|
| DMH1 |
DMH1 |
1206711-16-1 |
详细
|
| GLPG0634 |
GLPG0634 |
1206101-20-3 |
详细
|
| Fexinidazole |
非昔硝唑 |
59729-37-2 |
详细
|
| GDC-0941 |
GDC-0941 |
957054-30-7 |
详细
|
| GW788388 |
GW788388 |
452342-67-5 |
详细
|
| I-BET-762 |
(4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺 |
1260907-17-2 |
详细
|
| GSK2636771 |
GSK2636771 |
1372540-25-4 |
详细
|
| DY131(GSK 9089) |
N'-(4-(二乙氨基)亚苄基)-4-羟基苯甲酰肼 |
95167-41-2 |
详细
|
| GW-3965 hydrochloride |
2-[3-[3-[[2-氯-3-(三氟甲基)苄基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸盐酸盐 |
405911-17-3 |
详细
|
| ICG-001 |
ICG-001 |
847591-62-2 |
详细
|
| GSK2606414 |
GSK2606414 |
1337531-36-8 |
详细
|
| G-749 |
G-749 |
1457983-28-6 |
详细
|
| GSK-126 |
GSK126 |
1346574-57-9 |
详细
|
| GNE9605 |
GNE-9605 |
1536200-31-3 |
详细
|
| GSK-503 |
化合物GSK503 |
1346572-63-1 |
详细
|
| GO-6983 |
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
133053-19-7 |
详细
|
| EPZ-6438 |
EPZ-6438 |
1403254-99-8 |
详细
|
| 6-OAU(GTPL5846) |
GTPL5846 |
83797-69-7 |
详细
|
| GSK458 |
GSK2126458 |
1086062-66-9 |
详细
|
| ink128 |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
详细
|
| FK-506/Tacrolimus |
他克莫司 |
104987-11-3 |
详细
|
| LY294002 |
LY294002/PI3K抑制剂 |
154447-36-6 |
详细
|
| NS11394 |
3'-[5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-联苯]-2-甲腈 |
951650-22-9 |
详细
|
| OTSSP167 |
1-[6-(3,5-二氯-4-羟基苯基)-4-[[反式-4-[(二甲基氨基)甲基]环己基]氨基]-1,5-萘啶-3-基]-乙酮 |
1431697-89-0 |
详细
|
| ML323 |
ML323 |
1572414-83-5 |
详细
|
| LDN-212854 |
(LDN212854) |
1432597-26-6 |
详细
|
| CK-636 |
CK-636 |
442632-72-6 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| Nimorazole |
尼莫拉唑 |
6506-37-2 |
详细
|
| MDL 29951 |
MDL-29951 |
130798-51-5 |
详细
|
| CP-945598 |
CP945598 |
686347-12-6 |
详细
|
| NLG-919 |
1-环己基-2-(5H-咪唑并[5,1-A]异吲哚-5-基)乙醇 |
1402836-58-1 |
详细
|
| CHIR98014 |
CHIR98014(CT98014) |
252935-94-7 |
详细
|
| PF-670462 2HCl |
4-[1-环己基-4-(4-氟苯基)-1H-咪唑-5-基]-2-嘧啶胺盐酸盐 |
950912-80-8 |
详细
|
| JNJ31020028 |
JNJ 31020028 |
1094873-14-9 |
详细
|
| Kobe0065 |
N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE |
436133-68-5 |
详细
|
| mm-102 |
MM-102 |
1417329-24-8 |
详细
|
| LY-364947 |
LY 364947 |
396129-53-6 |
详细
|
| PD0325901 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 |
391210-10-9 |
详细
|
| PF-431396 |
N-甲基-N-[2-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]苯基]甲磺酰胺 |
717906-29-1 |
详细
|
| OTX-015 |
OTX-015 |
202590-98-5 |
详细
|
| MPS1-IN2 |
9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-B][1,4]二氮杂卓-6(7H)-酮 |
1228817-38-6 |
详细
|
| J-147 |
J-147 |
1146963-51-0 |
详细
|
| Bromosporine |
C17H20N6O4S |
1619994-69-2 |
详细
|
| ML-204 |
4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE |
5465-86-1 |
详细
|
| Nexturastat A |
4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE |
1403783-31-2 |
详细
|
| LY2584702 TsOH |
LY-2584702 |
1082949-67-4 |
详细
|
| LFM-A13 |
LFM-A13 |
244240-24-2 |
详细
|
| KB-R7943 mesylate |
KB-R7943 甲磺酰酸盐 |
182004-65-5 |
详细
|
| PD158780 |
N4-(3-溴苯基)-N6-甲基-吡啶并[3,4-D]嘧啶-4,6-二胺 |
171179-06-9 |
详细
|
| ML-141 |
ML 141 |
71203-35-5 |
详细
|
| MBX-2982 |
5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶 |
1037792-44-1 |
详细
|
| ML234 |
ML324 |
1222800-79-4 |
详细
|
| PD 169316 |
4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶 |
152121-53-4 |
详细
|
| MK-1775 |
MK-1775 |
955365-80-7 |
详细
|
| LH846 |
LH-846 |
639052-78-1 |
详细
|
| FK3311 |
N-[4-乙酰基-2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺 |
116686-15-8 |
详细
|
| Mdivi-1 |
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮 |
338967-87-6 |
详细
|
| LDN-214117 |
无中文名称 |
1627503-67-6 |
详细
|